Alessandra Ariaudo

A UHPLC–MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma

Alessandra Ariaudo, F. Favata, Amedeo De Nicolò et al. · Journal of Pharmaceutical and Biomedical Analysis · 2016 · 125 citations · Full text

Medicine, Antiviral Drug Development, Antiviral Therapy +8

HPLC–MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)

Antonio D’Avolio, Marco Simiele, Silvia De Francia et al. · Journal of Pharmaceutical and Biomedical Analysis · 2011 · 74 citations · Full text

Hematological Malignancy, Oncology, Medicine +10

UPLC–MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma

Marco Simiele, Alessandra Ariaudo, Amedeo De Nicolò et al. · Journal of Pharmaceutical and Biomedical Analysis · 2017 · 51 citations

Medicine, Uplc–ms/ms Method, Antiviral Drug Development +10

Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS

Lorena Baietto, Antonio D’Avolio, Cristina Marra et al. · Journal of Antimicrobial Chemotherapy · 2012 · 43 citations · Full text

Development and validation of an UPLC–PDA method to quantify daptomycin in human plasma and in dried plasma spots

Lorena Baietto, Antonio D’Avolio, Simone Pace et al. · Journal of Pharmaceutical and Biomedical Analysis · 2013 · 41 citations

Medicine, Bioanalysis, Human Plasma +9